Revvity, Inc. (RVTY) vs United Therapeutics Corporation (UTHR)
A side-by-side comparison of Revvity, Inc. and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.
RVTY
Revvity, Inc.
$145.73HealthcareDelayed quote: Sep 16, 2026, 4:00 PM EDT
UTHR
United Therapeutics Corporation
$498.48HealthcareDelayed quote: Sep 16, 2026, 4:00 PM EDT
Total return — RVTY vs UTHR
growth of $100 · dividends reinvested · last 10yRVTY +150.0% (+9.6%/yr)UTHR +312.8% (+15.2%/yr)UTHR compounded faster over this window
RVTY UTHR
RVTY vs UTHR: by the numbers
- •UTHR is the larger company ($21.16B vs $16.26B market cap).
- •UTHR trades at the lower trailing earnings multiple (17.86 vs 69.40 P/E), one valuation lens rather than an overall verdict.
- •UTHR converts more revenue to profit (41.56% vs 8.16% net margin).
- •UTHR grew revenue faster over the past five years (14.68% vs -9.69% CAGR).
- •RVTY pays a dividend (0.23% yield), while UTHR has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | RVTY | UTHR |
|---|---|---|
| P/E ratio | 69.40 | 17.86 |
| Forward P/E | 27.21 | 19.07 |
| P/S ratio | 5.58 | 6.71 |
| P/B ratio | 2.25 | 3.31 |
| EV / EBITDA | 24.09 | 12.95 |
| FCF yield | 3.44% | 5.17% |
Profitability
| Metric | RVTY | UTHR |
|---|---|---|
| Gross margin | 52.11% | 86.14% |
| Operating margin | 12.32% | 44.49% |
| Net margin | 8.16% | 41.56% |
| ROE | 3.29% | 20.48% |
| ROIC | 2.91% | 17.69% |
Dividends
| Metric | RVTY | UTHR |
|---|---|---|
| Dividend yield | 0.23% | N/A |
| Payout ratio | 13.33% | N/A |
Growth (annualized)
| Metric | RVTY | UTHR |
|---|---|---|
| Revenue CAGR (5Y) | -9.69% | 14.68% |
| EPS CAGR (5Y) | -20.48% | 20.93% |
| FCF CAGR (5Y) | -16.48% | 14.31% |
| Total return CAGR (5Y) | -7.62% | 19.17% |
Frequently asked
- Which has the lower trailing P/E, RVTY or UTHR?
- UTHR has the lower trailing P/E: RVTY trades at 69.40 and UTHR at 17.86. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, RVTY or UTHR?
- Over the past five years, UTHR grew revenue faster — RVTY at a -9.69% CAGR versus UTHR at 14.68%.
- Does RVTY or UTHR pay a bigger dividend?
- RVTY pays a dividend (0.23% yield), while UTHR has no payments in the available dividend history.
- Is RVTY or UTHR more profitable?
- UTHR runs the higher net margin — RVTY at 8.16% versus UTHR at 41.56%.
- How have RVTY and UTHR total returns compared?
- Over the past 10 years, RVTY delivered 9.26% and UTHR delivered 15.50% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Revvity P/E ratioUnited Therapeutics P/E ratioRevvity dividend yieldRevvity ROEUnited Therapeutics ROERevvity operating marginUnited Therapeutics operating marginRevvity revenue growthUnited Therapeutics revenue growthRevvity free cash flowUnited Therapeutics free cash flow
Revvity & United Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.